HOME >> BIOLOGY >> NEWS
Study calls for cheaper antitoxins for plant poisoning in less-developed countries

Antitoxins for plant poisoning and antidotes to snake venom should be included in the global drive to reduce costs and increase access to drugs in less-developed regions of the world, conclude authors of a research letter in this week's issue of THE LANCET.

Oleander self-poisoning is common in Sri Lanka-especially among young women-and an effective antitoxin was withdrawn after one year of use due to its high cost-around $2650 per treatment.

Michael Eddleston from the University of Colombo, Sri Lanka, and colleagues investigated the effect of the antitoxin's introduction and withdrawal on case fatality, and determined its cost-effectiveness. They report how the antitoxin strikingly reduced the case fatality; its absence resulted in a three-fold rise in deaths. At the present price of US$2650 per course, every life saved cost around $10,000, and every life year cost around $250. Reduction of the antitoxin's price to $400 would reduce costs to $1137 per life gained; a further reduction to $103 would save money for every life gained. Michael Eddleston comments: "There is presently a worldwide effort to develop and make available affordable drugs for tropical diseases; however, this effort seems to be passing by poisoning and envenoming. Treatments for poisoning and envenoming should be included in the campaign to increase the availability of affordable treatments. Both are significant problems in poor rural areas of the tropics, yet there is a dearth of affordable antivenoms for snake bites and antitoxins for plant poisoning. Although digoxin-specific antibodies were not patented on ethical grounds when developed in 1975, they are now unavailable in Sri Lanka because of their cost."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
25-Sep-2003


Page: 1

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, a ... announce that Eric Chen and Jessica Wong have joined the company’s leadership team ... respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, an ...
(Date:8/3/2020)... ... 2020 , ... Accumen Inc. is helping healthcare get better, ... Solutions, to provide COVID-19 saliva testing kits nationally. , “Accumen has been ... 10 years. Early in the COVID-19 crisis, we identified supply chain gaps and ...
(Date:7/22/2020)... ... July 21, 2020 , ... USDM Life Sciences ... compliance, announces a new solution to manage regulated workloads on Microsoft Azure. , ... technology stack complies with FDA and global regulations. USDM's new managed service for ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... TORONTO (PRWEB) , ... July 22, 2020 , ... Join ... and John Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar ... is the regulating body in China for drugs and medical devices. Specifically, for medical ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... to aid in the early detection and prevention of high-burden diseases, and Centric ... US-based hospitals and healthcare organizations to utilize existing data in order to identify ...
(Date:7/10/2020)... BALTIMORE (PRWEB) , ... July ... ... Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has ... This broader license allows PathSensors to move into the point-of-care diagnostic market, ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now ... up to 200 million stem cells. Depending on the patient's condition, treatment may be ... US will die having some form of Alzheimers dementia, and the incidence continues to ...
Breaking Biology Technology:
Cached News: